This study revealed an altered peripheral immune profile in DLB, with reduced proportions of CD4+ T cells and reduced activation of B cells in subjects with DLB, alongside a potential shift from naïve to terminal effector CD8+ T cells, suggesting an immunosenescent profile, as has been reported previously in AD [72]. The gene discussed is CD4; the disease is Alzheimer disease.